Perrigo (NYSE:PRGO) Rating Lowered to “Hold” at Wall Street Zen

by · The Markets Daily

Perrigo (NYSE:PRGO – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings upgraded shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, August 6th. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Perrigo presently has a consensus rating of “Reduce” and an average price target of $17.50.

Check Out Our Latest Stock Report on Perrigo

Perrigo Price Performance

Shares of NYSE:PRGO opened at $15.78 on Friday. Perrigo has a 12-month low of $9.23 and a 12-month high of $21.01. The company’s fifty day moving average is $14.83 and its two-hundred day moving average is $12.48. The company has a quick ratio of 1.32, a current ratio of 2.32 and a debt-to-equity ratio of 1.31. The company has a market cap of $2.19 billion, a P/E ratio of -1.26, a price-to-earnings-growth ratio of 1.82 and a beta of 0.71.

Perrigo (NYSE:PRGO – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.11. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The business’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.06) earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Equities analysts expect that Perrigo will post 2.17 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Perrigo

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Salomon & Ludwin LLC acquired a new stake in shares of Perrigo in the 3rd quarter valued at about $25,000. KBC Group NV lifted its stake in shares of Perrigo by 61.3% in the first quarter. KBC Group NV now owns 6,283 shares of the company’s stock worth $67,000 after buying an additional 2,388 shares during the last quarter. Parvin Asset Management LLC bought a new stake in Perrigo during the 2nd quarter worth about $79,000. Allworth Financial LP boosted its position in shares of Perrigo by 489.1% during the second quarter. Allworth Financial LP now owns 9,390 shares of the company’s stock worth $98,000 after purchasing an additional 7,796 shares in the last quarter. Finally, Whitebox Advisors LLC acquired a new stake in Perrigo in the first quarter valued at $111,000. Institutional investors and hedge funds own 95.91% of the company’s stock.

Perrigo Company Profile

(Get Free Report)

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.

Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.

See Also